Zituvimet Interactions
There are 404 drugs known to interact with Zituvimet (metformin/sitagliptin), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 25 are major, 367 are moderate, and 12 are minor.
- View all 404 medications that may interact with Zituvimet
- View Zituvimet alcohol/food interactions (2)
- View Zituvimet disease interactions (9)
Most frequently checked interactions
View interaction reports for Zituvimet (metformin / sitagliptin) and the medicines listed below.
- alfuzosin
- Annovera (ethinyl estradiol / segesterone)
- benztropine
- bisoprolol
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Briviact (brivaracetam)
- buprenorphine
- buspirone
- carisoprodol
- cilostazol
- cyanocobalamin
- dabigatran
- Dayvigo (lemborexant)
- Dilantin (phenytoin)
- Dilaudid (hydromorphone)
- doxylamine
- dutasteride
- enoxaparin
- Entyvio (vedolizumab)
- estradiol
- Evista (raloxifene)
- ezetimibe
- Farxiga (dapagliflozin)
- fentanyl
- FeroSul (ferrous sulfate)
- Fetzima (levomilnacipran)
- Flagyl (metronidazole)
- flecainide
- Focalin (dexmethylphenidate)
- Fycompa (perampanel)
Zituvimet alcohol/food interactions
There are 2 alcohol/food interactions with Zituvimet (metformin / sitagliptin).
Zituvimet disease interactions
There are 9 disease interactions with Zituvimet (metformin / sitagliptin) which include:
- lactic acidosis
- liver disease
- renal dysfunction
- renal dysfunction
- pancreatitis
- hypoglycemia
- B12 deficiency
- heart failure
- liver dysfunction
Report options
QR code containing a link to this page
More about Zituvimet (metformin / sitagliptin)
- Zituvimet consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.